Remdesivir in The Treatment of COVID-19.
Remdesivir in The Treatment of COVID-19.
复制标题
DOI：
10.1097/01.naj.0000731668.01845.8c
复制
发表时间：
2021-01
期刊：
影响因子：
--
通讯作者：
K. Rosenberg
中科院分区：
文献类型：
--
作者：
K. Rosenberg
根据这项研究：抗病毒药物瑞德西韦治疗COVID-19住院患者优于安慰剂。需要多种治疗方法来继续改善COVID-19患者的预后。
According to this study: The antiviral remdesivir is superior to placebo in the treatment of patients hospitalized with COVID-19.A variety of therapeutic approaches are needed to continue to improve outcomes in COVID-19 patients.